367 related articles for article (PubMed ID: 28117810)
1. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
Holzlöhner P; Hanack K
J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
[TBL] [Abstract][Full Text] [Related]
2. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
[TBL] [Abstract][Full Text] [Related]
3. Antibodies and Selection of Monoclonal Antibodies.
Hanack K; Messerschmidt K; Listek M
Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
[TBL] [Abstract][Full Text] [Related]
4. Production of monoclonal antibodies.
Yokoyama WM; Christensen M; Santos GD; Miller D; Ho J; Wu T; Dziegelewski M; Neethling FA
Curr Protoc Immunol; 2013 Oct; 102():2.5.1-2.5.29. PubMed ID: 24510488
[TBL] [Abstract][Full Text] [Related]
5. Hybridoma Technology.
Hnasko RM; Stanker LH
Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
[TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies.
Yokoyama WM
Curr Protoc Cell Biol; 2001 May; Chapter 16():Unit 16.1. PubMed ID: 18228333
[TBL] [Abstract][Full Text] [Related]
7. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A
Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419
[TBL] [Abstract][Full Text] [Related]
8. Hybridoma technologies for antibody production.
Tomita M; Tsumoto K
Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
[TBL] [Abstract][Full Text] [Related]
10. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
11. Production of monoclonal antibodies.
Yokoyama WM; Christensen M; Santos GD; Miller D
Curr Protoc Immunol; 2006 Sep; Chapter 2():2.5.1-2.5.25. PubMed ID: 18432969
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody specific for Δ12-prostaglandin J2 and its utilization in the immunological assay in cell culture system of adipocytes.
Syeda PK; Hossain MS; Chowdhury AA; Rahman MS; Khan F; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
Hybridoma (Larchmt); 2012 Oct; 31(5):364-71. PubMed ID: 23098304
[TBL] [Abstract][Full Text] [Related]
13. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique.
Stäuber N; Kihm U; McCullough KC
J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546
[TBL] [Abstract][Full Text] [Related]
14. Antibody engineering, a strategy for the development of monoclonal antibodies.
Schönherr OT; Houwink EH
Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
[TBL] [Abstract][Full Text] [Related]
15. Production of monoclonal antibodies.
Yokoyama WM
Curr Protoc Cytom; 2006 Aug; Appendix 3():Appendix 3J. PubMed ID: 18770829
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of monoclonal antibodies against human IgA in Balb/c mice.
Ezzatifar F; Majidi J; Baradaran B; Maleki LA; Abdolalizadeh J; Yousefi M
Hum Antibodies; 2014; 23(1-2):7-12. PubMed ID: 25812697
[TBL] [Abstract][Full Text] [Related]
17. High-throughput homogeneous immunoassay readily identifies monoclonal antibody to serovariant clostridial neurotoxins.
Corbett CR; Elias MD; Simpson LL; Yuan XY; Cassan RR; Ballegeer E; Kabani A; Plummer FA; Berry JD
J Immunol Methods; 2007 Dec; 328(1-2):128-38. PubMed ID: 17936779
[TBL] [Abstract][Full Text] [Related]
18. Hybridoma technology.
Price PJ
Ric Clin Lab; 1984; 14(3):277-86. PubMed ID: 6395287
[No Abstract] [Full Text] [Related]
19. B-cell receptor-based multitargeting method for simultaneous production of novel multiple monoclonal antibodies.
Obata H; Tsumoto K; Tomita M
J Biosci Bioeng; 2019 Nov; 128(5):578-584. PubMed ID: 31147218
[TBL] [Abstract][Full Text] [Related]
20. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
Power DA; Gerkis V; d'Apice AJ
Hum Antibodies Hybridomas; 1990; 1(1):34-41. PubMed ID: 2103351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
